Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens

Zika virus (ZIKV) is a major public health concern due to its overwhelming spread into the Americas. Currently, there are neither licensed vaccines nor antiviral therapies available for the treatment of ZIKV. We aimed to identify and rationally optimize effective therapeutic regimens for ZIKV by eva...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Pires de Mello, Camilly P., Tao, Xun, Kim, Tae Hwan, Bulitta, Jürgen B., Rodriquez, Jaime L., Pomeroy, Justin J., Brown, Ashley N.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740374/
https://ncbi.nlm.nih.gov/pubmed/29109164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01983-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars